UC San Francisco scientists have engineered human immune cells that can precisely locate diseased cells anywhere in the body and execute a wide range of customizable responses, including the delivery of drugs or other therapeutic payloads directly to tumors or other unhealthy tissues.

Some of UC San Francisco's foremost scientists will participate in the 2016 Dreamforce conference in San Francisco to talk on topics that include using technology to stop viral outbreaks, changing the way that cancer is fought and battling against the Zika virus.

Jin Kim, PhD, a postdoctoral scholar at UC San Francisco, won the inaugural UCSF Postdoc Slam competition for her talk titled “Promoting Smoking Cessation by Addressing Food Insecurity.”

Four UC San Francisco researchers are among the 84 Faculty Scholars named Thursday by the Howard Hughes Medical Institute (HHMI), the Simons Foundation and the Bill & Melinda Gates Foundation in a new program to support promising early-career scientists.

Three UCSF researchers have been awarded $680,000 in grants from Susan G. Komen to support projects in breast cancer research. 

By employing the same tactics it used to drive policymaking from the 1970s-1990s, the tobacco industry has become successful in influencing pro-industry e-cigarette laws at the state level, according to a UCSF study published in the September issue of Milbank Quarterly.

UCSF Benioff Children’s Hospitals are bringing together the cities of San Francisco and Oakland this week, as well as each city’s baseball team, to raise awareness of pediatric cancer and promote further research funding nationwide.

Ten recommendations from a Blue Ribbon Panel of scientific experts, cancer leaders and patient advocates – including two UC San Francisco researchers – have been approved to help guide the National Cancer Moonshot Initiative.

On September 9^th, millions of people across the United States and Canada are expected to tune into the fifth biennial Stand Up to Cancer broadcast raising money for cancer research. 

Early-stage breast cancer patients whose tumors carry genetic markers associated with a low risk of disease recurrence may not need to undergo chemotherapy, suggests a new study that employed a test devised by a UC San Francisco researcher.